S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
Stock market today: Futures climb as a miserable month for US markets nears its end. Crude nears $92
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Gold Really Boring? (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
US consumer confidence tumbles in September as American anxiety about the future grows
3 Household Names With RSIs That Scream Oversold
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
Stock market today: Futures climb as a miserable month for US markets nears its end. Crude nears $92
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Gold Really Boring? (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
US consumer confidence tumbles in September as American anxiety about the future grows
3 Household Names With RSIs That Scream Oversold
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
Stock market today: Futures climb as a miserable month for US markets nears its end. Crude nears $92
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Gold Really Boring? (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
US consumer confidence tumbles in September as American anxiety about the future grows
3 Household Names With RSIs That Scream Oversold
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
Stock market today: Futures climb as a miserable month for US markets nears its end. Crude nears $92
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Gold Really Boring? (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
The "Plug and Play" Model Putting Online Giants to Shame (Ad)
US consumer confidence tumbles in September as American anxiety about the future grows
3 Household Names With RSIs That Scream Oversold
LON:SBTX

SkinBioTherapeutics (SBTX) Share Forecast, Price & News

GBX 20.90
-0.35 (-1.65%)
(As of 11:30 AM ET)
Compare
Today's Range
20.51
▼
21.35
50-Day Range
11.90
▼
24.25
52-Week Range
11
▼
27
Volume
171,104 shs
Average Volume
427,636 shs
Market Capitalization
£36.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsInsider TradesHeadlines

SBTX stock logo

About SkinBioTherapeutics (LON:SBTX) Stock

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health. It develops SkinBiotix technology that can enhance the formation of multi-protein complexes and prevent passage toxins, molecules, and ions, as well as pathogens; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has a collaboration agreement with Croda Plc; and the University of Manchester to develop bacterial lysates in the prevention of periodontal gun disease. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.

SBTX Price History

SBTX Stock News Headlines

September 23, 2023 | americanbankingnews.com
SkinBioTherapeutics (LON:SBTX) Shares Down 1.2%
September 14, 2023 | uk.investing.com
Fiverr International Ltd DRC (F2VR34)
September 27, 2023 | Edge On The Street (Ad)
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
September 2, 2023 | uk.investing.com
Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA (ROH2O)
July 11, 2023 | finance.yahoo.com
SBTX.L - SkinBioTherapeutics Plc
June 21, 2023 | marketwatch.com
SkinBioTherapeutics Gets Approval for Supplement Launch in Italy
March 30, 2023 | finance.yahoo.com
SkinBioTherapeutics Reports First Half 2023 Earnings
March 28, 2023 | marketwatch.com
SkinBioTherapeutics Shares Fall on Widened 1H Pretax Loss From Higher Costs
September 27, 2023 | Wall Street Fundamentals (Ad)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
March 22, 2023 | finance.yahoo.com
Is SkinBioTherapeutics (LON:SBTX) In A Good Position To Invest In Growth?
December 21, 2022 | marketwatch.com
SkinBioTherapeutics Raises GBP2.6 Mln in Placing, Retail Offer
December 15, 2022 | marketwatch.com
SkinBioTherapeutics to Raise a Minimum of GBP2.5 Mln
October 14, 2022 | finance.yahoo.com
After losing 68% in the past year, SkinBioTherapeutics Plc (LON:SBTX) institutional owners must be relieved by the recent gain
August 31, 2022 | lse.co.uk
SkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales drop
August 31, 2022 | marketwatch.com
SkinBioTherapeutics Shares Fall After Worse-Than-Expected Supplement Sales
June 15, 2022 | proactiveinvestors.com
SkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatment
June 13, 2022 | marketwatch.com
SkinBioTherapeutics Knows No Reason For Share Price Fall
May 20, 2022 | news.yahoo.com
What It's Like Inside a Burning Drift Car
May 20, 2022 | news.yahoo.com
Report raises concerns over lay-offs, cash flow at Cottage clinic; records issues resolved
May 18, 2022 | finance.yahoo.com
We're Keeping An Eye On SkinBioTherapeutics' (LON:SBTX) Cash Burn Rate
March 29, 2022 | lse.co.uk
SkinBioTherapeutics proposes Manprit Singh Randhawa as new CFO
March 29, 2022 | marketwatch.com
SkinBioTherapeutics Shares Drop 30% After Widened 1H Pretax Loss
February 17, 2022 | finance.yahoo.com
What Kind Of Shareholders Hold The Majority In SkinBioTherapeutics Plc's (LON:SBTX) Shares?
January 19, 2022 | marketwatch.com
SkinBioTherapeutics CFO to Step Down
January 18, 2022 | proactiveinvestors.com
SkinBioTherapeutics seeks full-time finance chief and NED to guide social media strategy
December 24, 2021 | markets.businessinsider.com
SkinBioTherapeutics : Result of AGM
December 4, 2021 | markets.businessinsider.com
SkinBioTherapeutics : Notice of Results
See More Headlines
Receive SBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

SBTX Company Calendar

Last Earnings
3/03/2020
Today
9/27/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:SBTX
CUSIP
N/A
CIK
N/A
Web
www.skinbiotherapeutics.com
Phone
+44-161-4682760
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX (0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-3,000,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-111.74%
Return on Assets
-60.12%

Debt

Debt-to-Equity Ratio
9.03
Current Ratio
1.77
Quick Ratio
10.01

Sales & Book Value

Annual Sales
£21,949.00
Price / Sales
1,648.65
Cash Flow
GBX 2.32 per share
Price / Cash Flow
9.00
Book Value
GBX 1 per share
Price / Book
20.90

Miscellaneous

Outstanding Shares
173,140,000
Free Float
N/A
Market Cap
£36.19 million
Optionable
Not Optionable
Beta
2.17
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Stuart John Ashman (Age 56)
    CEO & Exec. Director
    Comp: $325.85k
  • Mr. Manprit Singh Randhawa (Age 39)
    CFO, Sec. & Director
    Comp: $177.98k
  • Dr. Catherine O'Neill
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Laura Bey
    Head of Formulations
  • Ms. Melissa Greenwell
    Group Financial Controller

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













SBTX Stock - Frequently Asked Questions

How have SBTX shares performed in 2023?

SkinBioTherapeutics' stock was trading at GBX 15.50 at the beginning of the year. Since then, SBTX shares have increased by 34.8% and is now trading at GBX 20.90.
View the best growth stocks for 2023 here.

How were SkinBioTherapeutics' earnings last quarter?

SkinBioTherapeutics Plc (LON:SBTX) released its earnings results on Tuesday, March, 3rd. The company reported ($0.64) EPS for the quarter.

What other stocks do shareholders of SkinBioTherapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Avacta Group (AVCT), Inspired (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG), Big Sofa Technologies Group (BST), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES) and Shield Therapeutics (STX).

What is SkinBioTherapeutics' stock symbol?

SkinBioTherapeutics trades on the London Stock Exchange (LON) under the ticker symbol "SBTX."

How do I buy shares of SkinBioTherapeutics?

Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is SkinBioTherapeutics' stock price today?

One share of SBTX stock can currently be purchased for approximately GBX 20.90.

How much money does SkinBioTherapeutics make?

SkinBioTherapeutics (LON:SBTX) has a market capitalization of £36.19 million and generates £21,949.00 in revenue each year. The company earns £-3,000,000.00 in net income (profit) each year or GBX (0.02) on an earnings per share basis.

How can I contact SkinBioTherapeutics?

SkinBioTherapeutics' mailing address is 15 1 Silk House, Park Green, MACCLESFIELD, SK11 7QJ, United Kingdom. The official website for the company is www.skinbiotherapeutics.com. The company can be reached via phone at +44-161-4682760.

This page (LON:SBTX) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -